Dubai: Dubai Airport Freezone Authority (DAFZA) announced that it will be participating in the 15th edition of Arab Health Exhibition and Congress “Arab Health 2019”, to highlight the competitive services and features that it provides for the healthcare sector. The event will be held at Dubai International Exhibition and Convention Centre on 28 - 31January.
DAFZA's participation in the region’s biggest and the world’s second biggest exhibition, comes to consolidate its presence in the healthcare and medical service industry in the region. It will also highlight the role it plays in attracting international key players in the industry to Dubai, in line with the Dubai Plan 2021 and economic diversification policies. The event is considered one of the key platforms for global companies aiming to showcase their services and products, and launch or expand their operations in the region. Investments in healthcare sector in the UAE is expected to reach $32.2 billion in 2027 up from $16.9 billion in 2017.
As a result of the great infrastructure facilities suitable for operations and growth, world-class services, and operational facilities provided by DAFZA; multinational companies represent 40% of the total companies operating in the healthcare, pharmaceuticals, health services and equipment industry at DAFZA
DAFZA will also be showcasing two packages; including the Premium, which provides a trade license, two residency visas, and a 25sqm furnished office space; and Premium Plus, which provides a trade license, six residency visas, and a 50sqm furnished office space.
Also at the event, DAFZA will be showcasing the features of its Light Industrial Units provided to these types of companies. The 350sqm insulated units can be used as storage and distribution warehouses, with an office on the ground floor. These options serve the different needs of companies in these sectors; from size, flexibility, cost efficiency, and competitive rates.
DAFZA’s participation will also include showcasing more than 2,000 new business domains which were introduced last July and can be selected for the trade license. The businesses were divided into 18 key categories, in line with the UN's International Standard Industrial Classification of All Economic Activities (ISIC4), which is the international standard of businesses globally.
This step was taken after a revision by DAFZA of the registration and licensing fees in 2018, and new investors’ visa fees. DAFZA’s registration fees were reduced by 65%, employee visa fees by 20%, certificate of origin fees by 17. These incentives facilitated providing new investors with public trading licenses, by decreasing the capital limit from AED1 million to AED500,000. The companies are also able to be incorporated as “Free Zone - Limited Liability Companies” to allow for a greater flexibility in incorporating, and operating businesses.
Healthcare companies operating within DAFZA include, Johnson & Johnson; Forever Living; Abbott Laboratories; MED-EL Medical Electronics; NSK Middle East; Paul Hartmann Middle East; Vygon Middle East; The Himalaya Drug Co; Hetero; Nipro Middle East; amongst other.
-Ends-
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
